Literature DB >> 20128050

Anti-inflammatory function of Nodosin via inhibition of IL-2.

Jiyu Li1, Junming Du, Lijuan Sun, Jianwen Liu, Zhiwei Quan.   

Abstract

In order to explore the anti-inflammatory effects of Nodosin from Isodon serra, a traditional Chinese herb medicine, mouse T lymphocytes were incubated with Nodosin. In the current study, Nodosin suppressed the overproduction of the T lymphocytes; moreover, cell mitosis cycle was modulated by interfering with DNA replication in G1 stages via inhibition of IL-2 cytokine secretion at the mRNA level by Nodosin. Interestingly, Xylene-induced mouse tumescence model results suggested Nodosin depressed the murine ear-swelling extent and the level of IL-2 in the blood serum. Finally, Nodosin possessed significant anti-inflammatory effects and is a potential candidate for further clinical trial.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128050     DOI: 10.1142/S0192415X10007713

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  Treatment of surgical brain injury by immune tolerance induced by intrathymic and hepatic portal vein injection of brain antigens.

Authors:  Weijian Yang; Yong Liu; Baolong Liu; Huajun Tan; Hao Lu; Hong Wang; Hua Yan
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

2.  Ent-Abietanoids Isolated from Isodon serra.

Authors:  Jun Wan; Hua-Yi Jiang; Jian-Wei Tang; Xing-Ren Li; Xue Du; Yan Li; Han-Dong Sun; Jian-Xin Pu
Journal:  Molecules       Date:  2017-02-17       Impact factor: 4.411

3.  Nodosin Exerts an Anti-Colorectal Cancer Effect by Inhibiting Proliferation and Triggering Complex Cell Death in Vitro and in Vivo.

Authors:  Huixia Fan; Xiaopeng Hao; Yuan Gao; Jian Yang; Aojun Liu; Yarui Su; Yong Xia
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 4.  Immune Tolerance Therapy: A New Method for Treatment of Traumatic Brain Injury.

Authors:  Ruo-Yang Feng; Qian Chen; Wei-Jian Yang; Xiao-Guang Tong; Zhi-Ming Sun; Hua Yan
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.